The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down's syndrome, Spina Bifida and Trisomy 18.

• Lyophilised for enhanced stability
• 100% human serum
• Monthly reporting
• Submit results and view reports online via RIQASNet
• Register up to five instruments at no extra cost
• Suitable for first and second trimester screening

Parameters

• AFP
• hCG, free beta
• hCG, total
• Inhibin A
• PAPP-A
• Unconjugated Oestriol